However, in vitro data suggest that TNF‐α may exert a neuroprotective effect by stimulating neuronal cells to express bcl‐2,18 which may explain the elevated risk of developing AD in APOE‐ε4 carriers with decreased TNF‐α levels. The gene discussed is BCL2; the disease is Alzheimer disease.